30
Participants
Start Date
April 30, 2006
Primary Completion Date
February 28, 2011
Study Completion Date
June 30, 2011
Alemtuzumab
Day 0: Campath 30 mg i.v. infusion over 3-6 hours
Rabbit Anti-Human Thymocyte Globulin
Day O: Single shot of a polyclonal antilymphocyte preparation (ATG-Fresenius - 8 mg/kg, or IMTIX-Sangstat ATG 4 mg/kg/day).
University Hospital Innsbruck, Innsbruck
Collaborators (1)
Astellas Pharma GmbH
INDUSTRY
Dr. Claudia Bösmüller
OTHER